Cardiol Therapeutics files US$150m preliminary base shelf prospectus
Cardiol Therapeutics filed a preliminary base shelf prospectus for US$150 million, including additional disclosure following review by Ontario Securities Commission staff.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.